Bill > B26-0101

This bill amends the Prohibition of Discrimination in the Provision of Insurance Act of 1986 to protect individuals using Pre-Exposure Prophylaxis (PrEP), a preventive medication for HIV. PrEP includes daily oral antiretroviral medications (such as combinations of tenofovir and emtricitabine) and extended-release injectable medications like cabotegravir. The bill prohibits insurance companies from discriminating against individuals using PrEP when issuing life, disability income, or long-term care insurance policies. Specifically, insurers cannot use PrEP usage as a factor in deciding whether to issue, renew, or cancel a policy, set rates or premiums, or determine policy terms and benefits. Insurers who violate these provisions will face fines ranging from $1,000 to $10,000 for each violation. The legislation aims to reduce barriers and stigma associated with HIV prevention medication, ensuring that individuals can access PrEP without fear of insurance discrimination. The bill will take effect after mayoral approval, congressional review, and publication in the District of Columbia Register.

Business and Industry

https://lims.dccouncil.gov/Legislation/B26-0101